The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

Twist Bioscience (TWST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to deliver approximately $3 million in cost savings in 2027 ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus FamilyNext-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle ...

BOULDER — Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round. Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round.

Paine Schwartz Partners–backed HGS BioScience, Jacksonville, Flordia, a leading provider of biological crop solutions, ...

On December 2, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations, of which NH Life Sciences is a member, released a new report, “The U.S. Bioscience ...

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

After striking out in the pandemic phase of COVID-19 with its belated vaccine, Novavax seeks to recover in the endemic phase. And a big part of the company's plan centers around enhancing its ...

Harvard Bioscience plans to close its manufacturing facility in Holliston, where the company also has its longtime corporate ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.